Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.75 EUR | -10.49% | -15.05% | +60.55% |
May. 16 | GeNeuro SA Announces Last Patient Last Visit in Its Post-Covid Trial and Confirms Top-Line Results by End of June 2024 | CI |
Mar. 20 | Geneuro SA Announces Appointments of Board of Directors | CI |
Sales 2024 * | 28.2M 30.18M | Sales 2025 * | - | Capitalization | 51.79M 55.43M |
---|---|---|---|---|---|
Net income 2024 * | 1M 1.07M | Net income 2025 * | -26M -27.83M | EV / Sales 2024 * | 2.12 x |
Net Debt 2024 * | 7.9M 8.45M | Net Debt 2025 * | 34.9M 37.35M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
58.3
x | P/E ratio 2025 * |
-2.01
x | Employees | 17 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 73.25% |
1 day | -10.49% | ||
1 week | -15.05% | ||
Current month | -10.26% | ||
1 month | +15.13% | ||
3 months | +38.34% | ||
6 months | +65.09% | ||
Current year | +60.55% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 05-12-31 | |
Hervé Perron
FOU | Founder | 66 | 05-12-31 |
Miguel Payró
DFI | Director of Finance/CFO | 62 | 15-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 21-05-26 | |
Michel Dubois
BRD | Director/Board Member | 81 | 08-07-15 |
Gordon Francis
BRD | Director/Board Member | 75 | 15-03-16 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-14 | 1.75 | -10.49% | 33,942 |
24-06-13 | 1.955 | -5.10% | 4,780 |
24-06-12 | 2.06 | +3.00% | 15,663 |
24-06-11 | 2 | +2.56% | 24,599 |
24-06-10 | 1.95 | -5.34% | 15,969 |
Real-time Euronext Paris, June 14, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+60.55% | 55.4M | |
+40.80% | 53.67B | |
+35.79% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |
- Stock Market
- Equities
- GNRO Stock